Cargando…
Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology
INTRODUCTION: The appeal of hyaluronic acid fillers for facial soft tissue augmentation is attributable to both an immediate aesthetic effect and relatively short recovery time. Although recovery time is an important posttreatment variable, as it impacts comfort with appearance and perceived treatme...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476436/ https://www.ncbi.nlm.nih.gov/pubmed/28652795 http://dx.doi.org/10.2147/CCID.S138155 |
_version_ | 1783244598920871936 |
---|---|
author | Swift, Arthur von Grote, Erika Jonas, Brandie Nogueira, Alessandra |
author_facet | Swift, Arthur von Grote, Erika Jonas, Brandie Nogueira, Alessandra |
author_sort | Swift, Arthur |
collection | PubMed |
description | INTRODUCTION: The appeal of hyaluronic acid fillers for facial soft tissue augmentation is attributable to both an immediate aesthetic effect and relatively short recovery time. Although recovery time is an important posttreatment variable, as it impacts comfort with appearance and perceived treatment benefit, it is not routinely evaluated. Natural-looking aesthetic outcomes are also a primary concern for many patients. MATERIALS AND METHODS: A single-center, noncomparative study evaluated the time (in hours) until subjects return to social engagement (RtSE) following correction of moderate and severe nasolabial folds (NLFs) with R(R) (Restylane(®) Refyne)(®) and R(D) (Restylane Defyne), respectively. Twenty subjects (aged 35–57 years) who received bilateral NLF correction documented their RtSE and injection-related events posttreatment. Treatment efficacy was evaluated by improvements in Wrinkle Severity Rating Scale (WSRS) and subject satisfaction questionnaire at days 14 and 30, and by Global Aesthetic Improvement Scale (GAIS) at day 30. Safety was evaluated by injection-related events and treatment-emergent adverse events. RESULTS: Fifty percent of subjects reported RtSE within 2 hours posttreatment. WSRS for the R(R) group improved significantly from baseline at day 14 (–1.45±0.42) and day 30 (–1.68±0.46) (P<0.001), respectively. WSRS for the R(D) group improved significantly from baseline at day 14 (–2.22±0.44) and day 30 (–2.50±0.50) (P<0.004), respectively. All GAIS improvements were clinically significant at day 30. The majority of injection-related events were mild or moderate. Two subjects experienced 3 related treatment-emergent adverse events; 1 R(R) subject experienced severe bruising, and 1 R(D) subject experienced severe erythema and mild telangiectasia. Subject satisfaction was high regarding aesthetic outcomes and natural-looking results. CONCLUSION: Optimal correction of moderate NLFs with R(R) and severe NLFs with R(D) involved minimal time to RtSE for most subjects. Treatments that significantly improved WSRS and GAIS, were generally well-tolerated, and provided natural-looking aesthetic outcomes. |
format | Online Article Text |
id | pubmed-5476436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54764362017-06-26 Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology Swift, Arthur von Grote, Erika Jonas, Brandie Nogueira, Alessandra Clin Cosmet Investig Dermatol Clinical Trial Report INTRODUCTION: The appeal of hyaluronic acid fillers for facial soft tissue augmentation is attributable to both an immediate aesthetic effect and relatively short recovery time. Although recovery time is an important posttreatment variable, as it impacts comfort with appearance and perceived treatment benefit, it is not routinely evaluated. Natural-looking aesthetic outcomes are also a primary concern for many patients. MATERIALS AND METHODS: A single-center, noncomparative study evaluated the time (in hours) until subjects return to social engagement (RtSE) following correction of moderate and severe nasolabial folds (NLFs) with R(R) (Restylane(®) Refyne)(®) and R(D) (Restylane Defyne), respectively. Twenty subjects (aged 35–57 years) who received bilateral NLF correction documented their RtSE and injection-related events posttreatment. Treatment efficacy was evaluated by improvements in Wrinkle Severity Rating Scale (WSRS) and subject satisfaction questionnaire at days 14 and 30, and by Global Aesthetic Improvement Scale (GAIS) at day 30. Safety was evaluated by injection-related events and treatment-emergent adverse events. RESULTS: Fifty percent of subjects reported RtSE within 2 hours posttreatment. WSRS for the R(R) group improved significantly from baseline at day 14 (–1.45±0.42) and day 30 (–1.68±0.46) (P<0.001), respectively. WSRS for the R(D) group improved significantly from baseline at day 14 (–2.22±0.44) and day 30 (–2.50±0.50) (P<0.004), respectively. All GAIS improvements were clinically significant at day 30. The majority of injection-related events were mild or moderate. Two subjects experienced 3 related treatment-emergent adverse events; 1 R(R) subject experienced severe bruising, and 1 R(D) subject experienced severe erythema and mild telangiectasia. Subject satisfaction was high regarding aesthetic outcomes and natural-looking results. CONCLUSION: Optimal correction of moderate NLFs with R(R) and severe NLFs with R(D) involved minimal time to RtSE for most subjects. Treatments that significantly improved WSRS and GAIS, were generally well-tolerated, and provided natural-looking aesthetic outcomes. Dove Medical Press 2017-06-14 /pmc/articles/PMC5476436/ /pubmed/28652795 http://dx.doi.org/10.2147/CCID.S138155 Text en © 2017 Swift et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Clinical Trial Report Swift, Arthur von Grote, Erika Jonas, Brandie Nogueira, Alessandra Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title | Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title_full | Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title_fullStr | Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title_full_unstemmed | Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title_short | Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology |
title_sort | minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with xpreshan technology |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476436/ https://www.ncbi.nlm.nih.gov/pubmed/28652795 http://dx.doi.org/10.2147/CCID.S138155 |
work_keys_str_mv | AT swiftarthur minimalrecoverytimeneededtoreturntosocialengagementfollowingnasolabialfoldcorrectionwithhyaluronicacidfillersproducedwithxpreshantechnology AT vongroteerika minimalrecoverytimeneededtoreturntosocialengagementfollowingnasolabialfoldcorrectionwithhyaluronicacidfillersproducedwithxpreshantechnology AT jonasbrandie minimalrecoverytimeneededtoreturntosocialengagementfollowingnasolabialfoldcorrectionwithhyaluronicacidfillersproducedwithxpreshantechnology AT nogueiraalessandra minimalrecoverytimeneededtoreturntosocialengagementfollowingnasolabialfoldcorrectionwithhyaluronicacidfillersproducedwithxpreshantechnology |